1
Published 2016
Canadian Agency for Drugs and Technologies in Health
... onset JIA (sJIA) is a subtype of the disease accounting for approximately 4% to 15% of patients...

2
Published 2016
Canadian Agency for Drugs and Technologies in Health
... onset JIA (sJIA) is a subtype of the disease accounting for approximately 4% to 15% of patients...

3
Published 2013
Canadian Agency for Drugs and Technologies in Health

4
Published 2017
CADTH
... in approximately one in every 12,000 to 15,000 infants born in North America, accounting for approximately 300 new...

5
Published 2017
CADTH
... in approximately one in every 12,000 to 15,000 infants born in North America, accounting for approximately 300 new...

6
by Tran, Khai
Published 2017
Canadian Agency for Drugs and Technologies in Health
...According to Canadian Cancer Statistics, bladder cancer is the fifth most common cancer, accounting...

8
by Tran, Khai
Published 2017
Canadian Agency for Drugs and Technologies in Health
...According to Canadian Cancer Statistics, bladder cancer is the fifth most common cancer, accounting...

10
Published 2015
Canadian Agency for Drugs and Technologies in Health
... and neovascular (wet) AMD (wAMD). While wAMD develops in only 10% to 20% of people with dry AMD, it accounts...

11
Published 2015
Canadian Agency for Drugs and Technologies in Health
... and neovascular (wet) AMD (wAMD). While wAMD develops in only 10% to 20% of people with dry AMD, it accounts...

12
Published 2011
Canadian Agency for Drugs and Technologies in Health

13
Published 2021
Canadian Agency for Drugs and Technologies in Health
... uncertainties remain, as the model did not account for the need for subsequent or adjunctive treatments...

14
Published 2014
Canadian Agency for Drugs and Technologies in Health
...Non-muscle (superficial) invasive bladder cancer accounted for about 6% of all cancers in Canada...

15
Published 2014
Canadian Agency for Drugs and Technologies in Health
...Non-muscle (superficial) invasive bladder cancer accounted for about 6% of all cancers in Canada...

16
Published 2014
Canadian Agency for Drugs and Technologies in Health
... which account for 99,000 deaths. Proper use of respiratory protection is a critical part of the process...

17
Published 2020
Canadian Agency for Drugs and Technologies in Health
... populations as distinct populations. CADTH also accounted for limitations by including relevant comparators...

18
Published 2014
Canadian Agency for Drugs and Technologies in Health
... which account for 99,000 deaths. Proper use of respiratory protection is a critical part of the process...

19
Published 2020
Canadian Agency for Drugs and Technologies in Health
... populations as distinct populations. CADTH also accounted for limitations by including relevant comparators...

20
Published 2019
Canadian Agency for Drugs and Technologies in Health
..., NHL accounts for 83% of all cases of lymphomas. In this context, axicabtagene ciloleucel is a chimeric...